Skip to Main Content

Paper Details

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma.
J Immunother
224
2019
CAR, CAR cells, Chimeric, Chimeric Antigen Receptor-transduced T Cells, EGFRvIII, Glioblastoma, Patients, Transduced cells, anti, anti-EGFRvIII, anti-EGFRvIII CAR, anti-EGFRvIII CAR T cells, anti-EGFRvIII CAR-transduced T cells, cancer, chimeric antigen receptor, epidermal growth factor receptor, genetically modified chimeric antigen receptor (CAR) lymphocytes, glioblastoma multiforme, hematologic malignancies, human, hypoxia, interleukin-2, patient, patients, recurrent glioblastoma, solid cancers
Author NameAffiliation
Nicholas P Restifo
Nicholas P Restifo
Mark RaffeldNational Cancer Institute, National Institutes of Health
Mark RaffeldNational Cancer Institute, National Institutes of Health
Howard A FineSandra and Edward Meyer Cancer Center, Weill Cornell Medical College
Steven A Rosenberg
Steven A Rosenberg
  • 1 - 7

Datasets

Release 1.2